Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

Part of paid clinical trials in Sacramento, California.

Sponsor
University of California, Davis
Study ID
NCT05886218
Status
Recruiting
Apply to this trial

Conditions

  • Sugammadex

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Quantitative Neuromuscular Function Monitoring — DEVICE
    Quantitative electromyographic (EMG) monitoring

Study Details

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

Key Dates

Start date
Feb 8, 2023
Status verified
Nov 2024
Primary completion
Jul 31, 2025
Completion
Jul 31, 2025

Study Design

Enrollment
215 participants (estimated)

Primary Outcome Measure

Oxygen desaturation [ Time Frame: 24 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UC Davis Medical CenterSacramentoCalifornia95817
Ana Arias
[email protected]
916-703-5456
Neal Fleming, MD, PhD
[email protected]
916 734-5046

Find similar trials in Sacramento, CA

By research site
UC Davis Medical Center· Sacramento, CA